Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study - Cristofanilli, M; Rugo, HS; Im, SA (Clin Cancer Res, 2022)